Check out Kristin Yarema & BioCentury on “Creating CAR T therapies that don’t cause cancer"


Johanna Mylet, C.P.A.

Chief Financial Officer

A headshot of Johanna Mylet

Ms. Mylet is our Chief Financial Officer, after joining the Company in 2015 and most recently serving as Senior Vice President, Finance following Poseida’s successful Series D financing and initial public offering in July 2020. Previously, Ms. Mylet was a controller at HUYA Bioscience International, and an audit manager at Grant Thornton, LLP, where she served life science companies across varying stages of development. She holds a Bachelor of Accountancy degree from the University of San Diego and is a Certified Public Accountant.

A headshot of Johanna Mylet